The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.

Reports Q4 revenue $191.5M, consensus $180.38M. “2024 was a record year for Upwork (UPWK), with full-year revenue, GAAP net income and adjusted ...

Reports Q4 revenue $430M, consensus $379.42M. “2024 marked the completion of a multi-year effort to transition the business into a highly ...

MERRILLVILLE, Ind. - NiSource Inc (NYSE:NI) reported strong financial results for 2024 on Wednesday, surpassing its own ...

Biogen expects 2025 non-GAAP EPS of $15.25-$16.25 and a mid-single-digit decline in total revenue, primarily due to MS franchise pressures, including potential biosimilar and generic entries. Growth ...

Biogen Inc. (NASDAQ:BIIB), currently valued at $19.15 billion by market capitalization, reported its earnings for the fourth ...

Cloudflare reported earnings that not only beat analyst estimates but also exceeded its own forecasts, highlighting robust ...

Bruker Corporation (Nasdaq: BRKR) today announced financial results for its fourth quarter and for the full year ended December 31, 2024. Frank H. Laukien, Bruker's ...

Kadant Inc. (NYSE: KAI) reported its financial results for the fourth quarter and fiscal year ended December 28, 2024. Fourth Quarter Financial Highlights ...